Trending stocks

L'Occitane International SA reports 37.0% Net Income growth and 11.7% Revenue growth

01/06/2015 • About L'Occitane International SA ($973) • By InTwits

L'Occitane International SA reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • L'Occitane International SA is a growth stock: FY2015 revenue growth was 11.7%, 5 year revenue CAGR was 14.0% at FY2015 ROIC 19.6%
  • L'Occitane International SA has medium CAPEX intensity: 5 year average CAPEX/Revenue was 5.7%. At the same time it's in pair with industry average of 6.2%.
  • CAPEX is quite volatile: 6.2 in 2015, 31.2 in 2014, 17.5 in 2013, 3.6 in 2012, 2.6 in 2011
  • The company has highly profitable business model: ROIC is at 19.6%
  • It operates with high leverage: Net Debt/EBITDA is -1.2x while industry average is -1.8x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

L'Occitane International SA ($973) key annual financial indicators

mln. €201120122013201420152015/2014
P&L
Revenue7729131,0431,0551,17811.7%
Gross Profit63775585585696312.6%
SG&A931021041116.4%
EBITDA16118920118423125.7%
Net Income1001211238912237.0%
Balance Sheet
Cash30030832031939523.8%
Short Term Debt64663-51.8%
Long Term Debt5465777410746.0%
Cash flow
Capex3656806150-17.2%
Ratios
Revenue growth26.1%18.3%14.2%1.1%11.7%
EBITDA growth14.8%17.6%6.4%-8.9%25.7%
Gross Margin82.5%82.7%82.0%81.1%81.8%0.7%
EBITDA Margin20.9%20.7%19.3%17.4%19.6%2.2%
Net Income Margin12.9%13.3%11.8%8.5%10.4%1.9%
SG&A, % of revenue10.2%9.7%9.9%9.4%-0.5%
CAPEX, % of revenue4.7%6.2%7.6%5.8%4.3%-1.5%
ROIC31.6%23.2%21.4%16.9%19.6%2.7%
ROE27.7%20.0%17.8%12.0%15.2%3.2%
Net Debt/EBITDA-1.5x-1.3x-1.2x-1.3x-1.2x0.1x

Revenue and profitability


The company's Revenue jumped on 11.7% in FY2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased slightly on 1.3 pp from 77.5% to 78.8% in 2015.

Gross Margin increased slightly on 0.67 pp from 81.1% to 81.8% in FY2015. SG&A as a % of Revenue showed almost no change in FY2015.

Net Income marign increased slightly on 1.9 pp from 8.5% to 10.4% in FY2015.

Capital expenditures (CAPEX) and working capital investments


In FY2015 the company had CAPEX/Revenue of 4.3%. The company's CAPEX/Revenue decreased slightly on 1.9 pp from 6.2% in FY2012 to 4.3% in FY2015. It's average CAPEX/Revenue for the last three years was 5.9%.

Return on investment


The company operates at good ROIC (19.60%) and ROE (15.19%). ROIC increased on 2.7 pp from 16.9% to 19.6% in FY2015. ROE increased on 3.2 pp from 12.0% to 15.2% in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is -1.2x and Debt / EBITDA is 0.5x. Net Debt / EBITDA increased on 0.1x from -1.3x to -1.2x in FY2015. Debt jumped on 38.8% in FY2015 while cash jumped on 23.8% in FY2015.

Management team


L'Occitane International SA's CEO is Reinold Geiger. Reinold Geiger has 17 years tenure at the company.

Appendix 1: Peers in Cosmetics/Personal Care


Below you can find L'Occitane International SA benchmarking vs. other companies in Cosmetics/Personal Care industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
EDS Wellness Holdings Ltd ($8176)-50.8%-98.6%1,059.5%238.8%
Vinda International Holdings Ltd ($3331)32.3%26.4%12.8%17.5%
Natural Beauty Bio-Technology Ltd ($157)21.8%-18.2%-9.1%15.1%
Ming Fai International Holdings Ltd ($3828)35.9%14.3%-0.1%-3.4%
China Child Care Corp Ltd ($1259)51.5%23.9%8.9%-13.4%
 
Median (7 companies)21.8%-5.0%-0.1%-3.4%
L'Occitane International SA ($973)18.3%14.2%1.1%11.7%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Natural Beauty Bio-Technology Ltd ($157)79.3%78.6%75.8%76.9%
China Child Care Corp Ltd ($1259)42.4%45.9%47.3%47.5%
EDS Wellness Holdings Ltd ($8176)23.6%-72.8%-43.6%39.8%
BaWang International Group Holding Ltd ($1338)38.8%41.9%48.5%37.4%
Vinda International Holdings Ltd ($3331)27.2%30.8%29.0%30.2%
 
Median (6 companies)33.0%36.4%38.2%38.6%
L'Occitane International SA ($973)82.5%82.7%82.0%81.1%81.8%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Natural Beauty Bio-Technology Ltd ($157)31.4%38.3%25.3%29.4%
Vinda International Holdings Ltd ($3331)13.9%16.1%14.2%15.3%
China Child Care Corp Ltd ($1259)18.3%19.4%18.6%14.2%
Ming Fai International Holdings Ltd ($3828)8.0%8.0%7.4%8.6%
EDS Wellness Holdings Ltd ($8176)-262.4%-1,026.9%-249.8%-13.7%
 
Median (7 companies)13.9%9.5%7.4%8.6%
L'Occitane International SA ($973)20.9%20.7%19.3%17.4%19.6%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
EDS Wellness Holdings Ltd ($8176)0.4%387.3%119.7%14.9%
Vinda International Holdings Ltd ($3331)16.2%20.5%20.2%12.9%
China Child Care Corp Ltd ($1259)4.6%2.7%10.1%7.8%
Natural Beauty Bio-Technology Ltd ($157)8.6%10.1%5.1%3.7%
BaWang International Group Holding Ltd ($1338)16.6%28.6%3.9%2.3%
 
Median (7 companies)5.5%10.1%6.6%3.7%
L'Occitane International SA ($973)4.7%6.2%7.6%5.8%4.3%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Natural Beauty Bio-Technology Ltd ($157)20.2%19.4%9.2%13.6%
China Child Care Corp Ltd ($1259)38.8%27.2%23.9%13.4%
Vinda International Holdings Ltd ($3331)11.4%13.8%10.4%10.0%
Ming Fai International Holdings Ltd ($3828)6.9%7.2%4.3%5.6%
EDS Wellness Holdings Ltd ($8176)-52.1%-5.3%-48.6%-8.4%
 
Median (7 companies)11.4%13.8%4.3%5.6%
L'Occitane International SA ($973)31.6%23.2%21.4%16.9%19.6%


Top companies by Net Debt / EBITDA

Top  FY2011 FY2012 FY2013 FY2014 FY2015
Vinda International Holdings Ltd ($3331)1.9x1.4x2.1x3.1x
Ming Fai International Holdings Ltd ($3828)-1.2x-1.5x-2.5x-2.1x
Natural Beauty Bio-Technology Ltd ($157)-3.0x-2.3x-4.6x-3.9x
China Child Care Corp Ltd ($1259)-3.0x-2.1x-2.7x-4.6x
 
Median (4 companies)-1.5x-1.9x-2.6x-3.0x
L'Occitane International SA ($973)-1.5x-1.3x-1.2x-1.3x-1.2x